Viagra recall likely

Pfizer has agreed to change the label despite arguing that no link has been found between Viagra and blindness.  In related developments, a safety officer at the FDA found exactly what the University of Minnesota scientists had found more than a year ago, but like for all other drugs like Prozac, Adderall, Accutane, Vioxx, Celebrex, Bextra, Crestor, Natrecor, Iressa, etc., either the FDA refused to act or acted too slowly in banning them.  In other words, FDA seems to be too close to the drug companies rather than working to ensure drug safety in America.  The safety officer’s experience was outlined in a letter to FDA Acting Commissioner Lester Crawford from Sen. Charles Grassley, R-Iowa, who said the agency had moved far too slowly on an emerging safety concern.

Pfizer has market Viagra aggressively, as it did it other drugs, including Celebrex and Bextra.  The FDA has in a few instances warned Pfizer about misleading ads.  FDA advises patients to stop taking these medicines, and call a doctor or healthcare provider right away if they experience sudden or decreased vision loss in one or both eyes. Further, patients taking or considering taking these products should inform their health care professionals if they have ever had severe loss of vision, which might reflect a prior episode of NAION. Such patients are at an increased risk of developing NAION again.